Study Summary
This trial will test if an automated geriatric care program can manage patients before, during, and after surgery.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 2 years
2 years
feasibility of automated geriatric co-management program
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
In-person geriatric co-management group
1 of 2
Automated geriatric co-management program group
1 of 2
Active Control
Experimental Treatment
20 Total Participants · 2 Treatment Groups
Primary Treatment: automated geriatric co-management · No Placebo Group · N/A
Automated geriatric co-management program group
Other
Experimental Group · 1 Intervention: automated geriatric co-management · Intervention Types: OtherIn-person geriatric co-management group
Other
ActiveComparator Group · 1 Intervention: in-person geriatric co-management · Intervention Types: OtherTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,832 Previous Clinical Trials
584,548 Total Patients Enrolled
Armin Shahrokni, MD, MPHPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
1 Previous Clinical Trials
100 Total Patients Enrolled
Eligibility Criteria
Age 65+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:A solid mass or nodule that is suspicious for cancer can be a cause of concern
consideration for surgical resection of the solid mass or nodule is being given, with an anticipated hospital length of stay of at least two days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments